Prognostic factors in clinical stage I non–small cell lung cancer

Slides:

Advertisements

Similar presentations

Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,

Advertisements

Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab Tomoko Funazo,

Histopathologic Prognostic Factors in Resected Colorectal Lung Metastases Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida, MD,

Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis Nathan M. Mollberg, DO,

Limited resection trial for pulmonary ground-glass opacity nodules: Fifty-case experience Junji Yoshida, MD, Kanji Nagai, MD, Tomoyuki Yokose, MD, Mitsuyo.

Quality of life after tailored combined surgery for stage I non–small-cell lung cancer and severe emphysema Eugenio Pompeo, MD, Enrico De Dominicis,

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.

Prognostic significance of histologic differentiation, carcinoembryonic antigen value, and lymphovascular invasion in stage I non–small cell lung cancer

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

The impact on survival of positive intraoperative pleural lavage cytology in patients with non–small-cell lung cancer Keiju Aokage, MD, Junji Yoshida,

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer Kyong-Ah Yoon,

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Predictive Factors for Local Recurrence of Resected Colorectal Lung Metastases Satoshi Shiono, MD, Genichiro Ishii, MD, Kanji Nagai, MD, Junji Yoshida,

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis Naoto Morimoto,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Neither Maximum Tumor Size nor Solid Component Size Is Prognostic in Part-Solid Lung Cancer: Impact of Tumor Size Should Be Applied Exclusively to Solid.

Importance of Ground Glass Opacity Component in Clinical Stage IA Radiologic Invasive Lung Cancer Aritoshi Hattori, MD, Takeshi Matsunaga, MD, Kazuya.

Trimodal Therapy for Histologically Proven N2/3 Non–Small Cell Lung Cancer: Mid-Term Results and Indicators for Survival Volker Steger, MD, Thorsten.

Pneumonectomy for stage i (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival Christos Alexiou, FRCS, David Beggs, FETCS,

Combined Resection of Superior Vena Cava for Lung Carcinoma: Prognostic Significance of Patterns of Superior Vena Cava Invasion Kenji Suzuki, MD, Hisao.

Sex-associated differences in survival of patients undergoing resection for lung cancer Mark K Ferguson, MD, Jun Wang, MD, Philip C Hoffman, MD, Daniel.

Long-Term Outcomes After Surgical Resection of Pulmonary Metastases From Colorectal Cancer Hisashi Suzuki, MD, PhD, Moriyuki Kiyoshima, MD, Miyuki Kitahara,

Mariano Garcı́a-Yuste, MD, José M

Liver Metastasis Is Associated with Poor Progression-Free Survival in Patients with Non–Small Cell Lung Cancer Treated with Nivolumab Tomoko Funazo,

Lung Cancer Surgery in Patients With Liver Cirrhosis

Influence of Cigarette Smoking on Survival and Tumor Invasiveness in Clinical Stage IA Lung Adenocarcinoma Ryo Maeda, MD, Junji Yoshida, MD, Genichiro.

Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu,

Expression of Nuclear Factor-κB and Its Clinical Significance in Nonsmall-Cell Lung Cancer Zhenfa Zhang, MD, Jianqun Ma, MD, Ni Li, PhD, Nan Sun, MD,

Conditional Survival After Surgical Intervention in Patients With Non-Small Cell Lung Cancer Takayuki Fukui, MD, Toshiki Okasaka, MD, Koji Kawaguchi,

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Treatment strategy for chylothorax after pulmonary resection and lymph node dissection for lung cancer Kimihiro Shimizu, MD, Junji Yoshida, MD, Mituyo.

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Extratumoral Vascular Invasion Is a Significant Prognostic Indicator and a Predicting Factor of Distant Metastasis in Non-small Cell Lung Cancer Yoshihisa.

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Prognostic Impact of Node Involvement Pattern in Pulmonary pN1 Squamous Cell Carcinoma Patients Masayuki Nakao, MD, Junji Yoshida, MD, PhD, Genichiro.

Fibrous Stroma Is Associated with Poorer Prognosis in Lung Squamous Cell Carcinoma Patients Yusuke Takahashi, MD, Genichiro Ishii, MD, Tetsuhiko Taira,

Pulmonary Resection for Lung Cancer in Octogenarians

Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung Marc Riquet, MD, Dominique Manac’h, MD, Françoise Le.

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Visceral Pleural Invasion Classification in Non-small Cell Lung Cancer

The Prognostic Impact of Cigarette Smoking on Patients with Non-small Cell Lung Cancer Ryo Maeda, MD, Junji Yoshida, MD, PhD, Genichiro Ishii, MD, PhD,

Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,

Douglas E. Paull, MD, Glenda M. Updyke, PA-C, Michael A

Prognosis of Resected Non-Small Cell Lung Cancer Patients with Intrapulmonary Metastases Kanji Nagai, MD, Yasunori Sohara, MD, Ryosuke Tsuchiya, MD,

Visceral Pleura Invasion Impact on Non-small Cell Lung Cancer Patient Survival: Its Implications for the Forthcoming TNM Staging Based on a Large-Scale.

Prognostic Significance of Aberrant Methylation of Solute Carrier Gene Family 5A8 in Lung Adenocarcinoma Koei Ikeda, MD, PhD, Kenji Shiraishi, MD, PhD,

Menopausal effects on presentation, treatment, and survival of women with non–small cell lung cancer Kimberly A Moore, MD, Carlos M Mery, MD, MPH, Michael.

Edwin van Velzen, MD, Aart Brutel de la Rivière, MD, PhD, Hans J

Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD

Neal S Goldstein, MD The Annals of Thoracic Surgery

Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients Patrick Bagan, MD, Jalal Assouad, MD, Pascal Berna, MD,

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker Adnan Sayar,

Aritoshi Hattori, MD, Kenji Suzuki, MD

Results of Initial Operations in Non–Small Cell Lung Cancer Patients With Single-Level N2 Disease Yasuhiko Ohta, MD, Yosuke Shimizu, MD, Hiroshi Minato,

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma Joachim Pfannschmidt, MD, Hans Hoffmann, MD, PhD, Thomas.

Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms Robert E. Merritt, MD, Douglas J. Mathisen,

Visceral Pleural Invasion Is Not a Significant Prognostic Factor in Patients With a Part- Solid Lung Cancer Aritoshi Hattori, MD, Kenji Suzuki, MD, Takeshi.

A phase II single-institution study of neoadjuvant stage IIIA/B chemotherapy and radiochemotherapy in non-small cell lung cancer Andreas Granetzny, MD,

Presentation transcript:

Prognostic factors in clinical stage I non–small cell lung cancer Kenji Suzuki, MD, Kanji Nagai, MD, Junji Yoshida, MD, Eiji Moriyama, MD, Mitsuyo Nishimura, MD, Kenro Takahashi, MD, Yutaka Nishiwaki, MD The Annals of Thoracic Surgery Volume 67, Issue 4, Pages 927-932 (April 1999) DOI: 10.1016/S0003-4975(99)00140-X

Fig 1 Survival curve for patients with clinical stage I non–small cell lung cancer. Bars indicate 99% confidence intervals (CI). The Annals of Thoracic Surgery 1999 67, 927-932DOI: (10.1016/S0003-4975(99)00140-X)

Fig 2 Survival by clinical T status patients with clinical stage I non–small cell lung cancer. A significant differences was observed (p < 0.001, log-rank test). The Annals of Thoracic Surgery 1999 67, 927-932DOI: (10.1016/S0003-4975(99)00140-X)

Fig 3 Survival by serum carcinoembryonic antigen (CEA) level for patients with clinical stage I non–small cell lung cancer. A significant difference was observed (p = 0.005, log-rank test). The Annals of Thoracic Surgery 1999 67, 927-932DOI: (10.1016/S0003-4975(99)00140-X)

Fig 4 Survival by clinical T status and serum carcinoembryonic antigen levels patients with clinical stage I non–small cell lung cancer. A significant difference was observed (p < 0.001, log-rank test). The Annals of Thoracic Surgery 1999 67, 927-932DOI: (10.1016/S0003-4975(99)00140-X)

The Annals of Thoracic Surgery 1999 67, 927-932DOI: (10 The Annals of Thoracic Surgery 1999 67, 927-932DOI: (10.1016/S0003-4975(99)00140-X)